Dashboard
Manage Tickers

RMD RESMED INC

NYSE resmed.com


$ 246.10 $ -2.55 (-1.02 %)    

Tuesday, 04-Nov-2025 17:16:53 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 615.11 $ -4.04 (-0.65 %)
DIA $ 470.25 $ 0.57 (0.12 %)
SPY $ 672.36 $ -0.79 (-0.12 %)
TLT $ 90.13 $ 0.15 (0.17 %)
GLD $ 362.19 $ -1.27 (-0.35 %)
$ 246.4
$ 247.71
$ 241.20 x 12
$ 252.00 x 9
$ 243.14 - $ 247.71
$ 199.07 - $ 293.81
1,447,258
na
35.97B
$ 1.03
$ 25.01
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-31-2025 09-30-2025 10-Q
2 08-08-2025 06-30-2025 10-K
3 04-23-2025 03-31-2025 10-Q
4 01-31-2025 12-31-2024 10-Q
5 10-24-2024 09-30-2024 10-Q
6 08-09-2024 06-30-2024 10-K
7 04-25-2024 03-31-2024 10-Q
8 01-25-2024 12-31-2023 10-Q
9 10-26-2023 09-30-2023 10-Q
10 08-11-2023 06-30-2023 10-K
11 04-28-2023 03-31-2023 10-Q
12 01-27-2023 12-31-2022 10-Q
13 10-28-2022 09-30-2022 10-Q
14 08-12-2022 06-30-2022 10-K
15 04-28-2022 03-31-2022 10-Q
16 01-27-2022 12-31-2021 10-Q
17 10-28-2021 09-30-2021 10-Q
18 08-17-2021 06-30-2021 10-K
19 04-30-2021 03-31-2021 10-Q
20 01-29-2021 12-31-2020 10-Q
21 10-30-2020 09-30-2020 10-Q
22 08-13-2020 06-30-2020 10-K
23 05-01-2020 03-31-2020 10-Q
24 01-31-2020 12-31-2019 10-Q
25 10-25-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-K
27 05-03-2019 03-31-2019 10-Q
28 02-01-2019 12-31-2018 10-Q
29 10-26-2018 09-30-2018 10-Q
30 08-17-2018 06-30-2018 10-K
31 04-27-2018 03-31-2018 10-Q
32 01-24-2018 12-31-2017 10-Q
33 10-27-2017 09-30-2017 10-Q
34 08-04-2017 06-30-2017 10-K
35 04-28-2017 03-31-2017 10-Q
36 01-25-2017 12-31-2016 10-Q
37 10-28-2016 09-30-2016 10-Q
38 08-05-2016 06-30-2016 10-K
39 04-29-2016 03-31-2016 10-Q
40 01-28-2016 12-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nvidia-to-rally-around-73-here-are-10-top-analyst-forecasts-for-monday
Nvidia To Rally Around 73%? Here Are 10 To...
11/03/2025 14:23:56

baird-maintains-outperform-on-resmed-lowers-price-target-to-300
Baird Maintains Outperform on ResMed, Lowe...
11/03/2025 12:32:28

Baird analyst Joe Vruwink maintains ResMed (NYSE:RMD) with a Outperform and lowers the price target from $320 to $300.

nasdaq-100-rebounds-amazon-jumps-10-on-strong-earnings-whats-moving-markets-friday
Nasdaq 100 Rebounds, Amazon Jumps 10% On S...
10/31/2025 17:26:36

Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap gi...

rbc-capital-maintains-outperform-on-resmed-raises-price-target-to-303
RBC Capital Maintains Outperform on ResMed...
10/31/2025 15:08:13

RBC Capital analyst Craig Wong-Pan maintains ResMed (NYSE:RMD) with a Outperform and raises the price target from $300 to $303.

these-analysts-revise-their-forecasts-on-resmed-following-q1-results
These Analysts Revise Their Forecasts On R...
10/31/2025 13:24:04

keybanc-maintains-overweight-on-resmed-raises-price-target-to-299
Keybanc Maintains Overweight on ResMed, Ra...
10/31/2025 13:11:17

Keybanc analyst Brett Fishbin maintains ResMed (NYSE:RMD) with a Overweight and raises the price target from $298 to $299.

mizuho-maintains-outperform-on-resmed-lowers-price-target-to-300
Mizuho Maintains Outperform on ResMed, Low...
10/31/2025 12:04:24

Mizuho analyst Anthony Petrone maintains ResMed (NYSE:RMD) with a Outperform and lowers the price target from $310 to $300.

resmed-q1-adj-eps-255-beats-250-estimate-sales-1336b-beat-1331b-estimate
ResMed Q1 Adj. EPS $2.55 Beats $2.50 Estim...
10/30/2025 20:09:48

ResMed (NYSE:RMD) reported quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $2.50 by 2.04 per...

meta-tumbles-10-google-marks-historic-rally-whats-moving-markets-thursday
Meta Tumbles 10%, Google Marks Historic Ra...
10/30/2025 17:40:46

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the me...

earnings-scheduled-for-october-30-2025
Earnings Scheduled For October 30, 2025
10/30/2025 11:12:06

insights-into-resmeds-upcoming-earnings
Insights into ResMed's Upcoming Earnings
10/29/2025 16:02:52

what-9-analyst-ratings-have-to-say-about-resmed
What 9 Analyst Ratings Have To Say About R...
10/21/2025 13:02:18

slb-to-rally-around-44-here-are-10-top-analyst-forecasts-for-tuesday
SLB To Rally Around 44%? Here Are 10 Top A...
10/21/2025 13:02:06

morgan-stanley-maintains-overweight-on-resmed-raises-price-target-to-304
Morgan Stanley Maintains Overweight on Res...
10/21/2025 11:53:18

Morgan Stanley analyst Sean Laaman maintains ResMed (NYSE:RMD) with a Overweight and raises the price target from $298 to $304.

resmed-stock-a-deep-dive-into-analyst-perspectives-9-ratings
ResMed Stock: A Deep Dive Into Analyst Per...
09/18/2025 20:00:54

this-progressive-analyst-is-no-longer-bullish-here-are-top-3-downgrades-for-thursday
This Progressive Analyst Is No Longer Bull...
09/18/2025 14:00:34

this-target-analyst-begins-coverage-on-a-bearish-note-here-are-top-5-initiations-for-thursday
This Target Analyst Begins Coverage On A B...
09/18/2025 11:30:38

citigroup-initiates-coverage-on-resmed-with-buy-rating-announces-price-target-of-330
Citigroup Initiates Coverage On ResMed wit...
09/18/2025 11:21:32

Citigroup analyst Laura Sutcliffe initiates coverage on ResMed (NYSE:RMD) with a Buy rating and announces Price Target of $330.

the-analyst-verdict-resmed-in-the-eyes-of-8-experts
The Analyst Verdict: ResMed In The Eyes Of...
08/01/2025 19:03:05

resmed-analysts-increase-their-forecasts-after-strong-q2-earnings
ResMed Analysts Increase Their Forecasts A...
08/01/2025 18:16:26

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION